GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer ScreeningMENLO PARK, Calif., Jan....
Read moreDetails